Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 6 33-6, 1996, Pages

  Lee, Min A E ^b   Böhm, Manfred ^b   Paul, Martin ^a   Bader, Michael ^b   Ganten, Ursula ^b   Ganten, Detlev ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

hypertension; renin angiotensin system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; RENIN;

BLOOD PRESSURE REGULATION; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TRANSGENE; TRANSGENIC ANIMAL;

EID: 0000561070     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.6.e919     Document Type: Review

References (92)

1. Allen, A. M., S. Y. Chai, P. M. Sexton, S. J. Lewis, A. J. M. Verberne, B. Jarrott, W. J. Louis, J. Clevers, M. J. McKinley, G. Paxinos, and F. A. O. Mendelsohn. Angiotensin II receptors and angiotensin converting enzyme in the medulla oblongata. Hypertension Dallas 9: 197-205, 1987.
2. Bachmann, J., U. Ganten, F. Zimmermann, J. J. Mullins, G. Stock, and D. Ganten. Sexual dimorphism of blood pressure in transgenic rats TGR(mREN2)27 harboring the murine Ren-2 gene. In: Colloque INSERM, Genetic Hypertension, edited by J. Sassard. Paris: John Libbey Eurotext, 1992, vol. 218, p. 353-355.
3. Bachmann, S., J. Peters, E. Engler, D. Ganten, and J. Mullins. Transgenic rats carrying the mouse renin gene - morphological characterization of a low renin hypertension model. Kidney Int. 41: 24-36, 1992.
4. Bader, M., Y. Zhao, M. Sander, M. Lee, J. Bachmann, M. Böhm, B. Djavidani, J. Peters, J. J. Mullins, and D. Ganten. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension Dallas 19: 681-686, 1992.
5. Baker, K. M., and J. F. Aceto. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H610-H618, 1990.
6. Barrett, G., D. Ogg, J. Peters, S. Fleming, C. Whitworth, and J. J. Mullins. Hypertension and cardiac hypertrophy as a result of high circulating prorenin levels (Abstract). J. Hypertens. 12: S173, 1994.
7. Bastide, B., L. Neyses, D. Ganten, M. Paul, K. Willecke, and O. Traub. Gap junction protein connexin-40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circ. Res. 73: 1138-1149, 1993.
8. Böhm, M., M. A. Lee, R. Kreutz, S. Kim, M. Schinke, B. Djavidani, J. Wagner, M. Kaling, W. Wienen, M. Bader, and D. Ganten. Angiotensin II receptor blockade in TGR(m-REN2)27: effects of renin-angiotensin system gene expression and cardiovascular functions. J. Hypertens. 13: 891-899, 1995.
9. Böhm, M., M. Moll, B. Schmid, M. Paul, D. Ganten, M. Castellano, and E. Erdmann. Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension Dallas 24: 653-662, 1994.
10. Campbell, D. J., P. Rong, A. Kladis, B. Rees, and S. L. Skinner. Angiotensin and bradykinin peptides in the TGR(m-REN-2)27 rat. Hypertension Dallas 25: 1014-1020, 1995.
11. Chen, Y.-F., A. J. Naftilan, and S. Oparil. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension Dallas 19: 456-463, 1992.
12. Cheng, H. F., B. N. Becker, K. D. Burns, and R. C. Harris. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J. Clin. Invest. 95: 2012-2029, 1995.
13. Dawber, T. R. The Framingham Study. The Epidemiology of Atherosclerotic Disease. Cambridge, MA: Harvard University Press, 1980.
14. Deddish, P., J. Wang, B. Michel, P. W. Morris, N. O. Davidson, R. A. Skidgel, and E. G. Erdös. Naturally occurring active N-domain of human angiotensin I-converting enzyme. Proc. Natl. Acad. Sci. USA 91: 7807-7811, 1994.
15. Do, Y. S., A. Sherrod, R. A. Lobo, R. J. Paulson, T. Shinagawa, S. Chen, S. Kjos, and W. A. Hsueh. Human ovarian theca cells are a source of renin. Proc. Natl. Acad. Sci. USA 85: 1957-1961, 1988.
16. Dzau, V. J. Possible prorenin activating mechanisms in the blood vessel wall. J. Hypertens. Suppl. 5, Suppl. 2: S15-S18, 1987.
17. Dzau, V. J., J. Ingelfinger, R. E. Pratt, and K. E. Ellison. Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension Dallas 8: 544-548, 1986.
18. Dzau, V. J., and R. N. Re. Evidence for the existence of renin in the heart. Circulation 75, Suppl. I: I134-I136, 1987.
19. Field, L. J. Cardiovascular research in transgenic animals. Trends Cardiovasc. Med. 1: 141-146, 1991.
20. Ganten, D., K. Lindpaintner, U. Ganten, J. Peters, F. Zimmermann, M. Bader, and J. Mullins. Transgenic rats: new animal models in hypertension research. Hypertension Dallas 17: 843-855, 1991.
21. Ganten, U., G. Schröder, M. Witt, F. Zimmermann, D. Ganten, and G. Stock. Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. J. Hypertens. 7: 721-726, 1989.
22. Gross, V., R. J. Roman, and A. W. Cowley. Abnormal pressure-natriuresis in transgenic renin gene rats. J. Hypertens. 12: 1029-1034, 1994.
23. Gutkowska, J., P. Corvol, A. F. S. Figueiredo, T. Inagami, J. Bouhnik, and J. Genest. Kinetic studies of rat renin and tonin on purified rat angiotensinogen. Can. J. Biochem. Cell Biol. 62: 137-142, 1984.
24. Hanahan, D. Transgenic mice as probes into complex systems. Science Wash. DC 246: 1265-1275, 1989.
25. Hein, L., G. S. Barsh, R. E. Pratt, V. J. Dzau, and B. K. Kobilka. Behaviourial and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature Lond. 377: 744-747, 1995.
26. Hilgers, K. F., J. Peters, R. Veelken, M. Sommer, G. Rupprecht, D. Ganten, F. C. Luft, and J. F. E. Mann. Increased vascular angiotensin formation in female rats harboring the mouse Ren-2 gene. Hypertension Dallas 19: 687-691, 1992.
27. Hilgers, K. F., R. Veelken, I. Kreppner, D. Ganten, F. C. Luft, H. Geiger, and J. F. E. Mann. Vascular angiotensin and the sympathetic nervous system: do they interact? Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H187-H194, 1994.
28. Hogan, B., F. Costantini, and E. Lacy. Manipulating the Mouse Embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1986.
29. Hosoi, M., S. Kim, T. Yamauchi, T. Watanabe, K. Murakami, F. Suzuki, A. Takahashi, Y. Nakamura, and K. Yamamoto. Similarity between physicochemical properties of recombinant rat prorenin and native inactive renin. Biochem. J. 275: 727-731, 1991.
30. Ichiki, T., P.A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. L. M. Hogan, and T. Inagami. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature Lond. 377: 748-750, 1995.
31. Izumo, S., B. Nadal-Ginard, and V. Mahdavi. Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. USA 85: 339-343, 1988.
32. Johns, D. W., M. J. Peach, R. A. Gomez, T. Inagami, and R. M. Carey. Aagiotensin II regulates renin gene expression. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F882-F887, 1990.
33. Kambayashi, Y., S. Bardhan, K. Takahashi, S. Tsuzuki, H. Inui, T. Hamakubo, and T. Inagami. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268: 24543-24546, 1993.
34. Kim, S., M. Hosoi, F. Ikemoto, K. Murakami, Y. Ishizuka, and K. Yamamoto. Conversion to renin of exogenously administered recombinant human prorenin in liver and kidney of monkeys. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E451-E458, 1990.
35. Krege, J. H., S. W. M. John, L. L. Langenbach, J. B. Hodgin, J. R. Hagaman, E. S. Bachman, J. C. Jennette, D. A. O'Brien, and O. Smithies. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature Lond. 375: 146-148, 1995.
36. Kumar, R. S., J. Kusari, S. N. Roy, R. L. Soffer, and G. C. Sen. Structure of testicular angiotensin-converting enzyme. J. Biol. Chem. 264: 16754-16758, 1989.
37. Kurtz, T. W., L. Simonet, P. M. Kabra, S. Wolfe, L. Chan, and B. L. Hjelle. Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J. Clin. Invest. 85: 1328-1332, 1990.
38. Lafayette, R. A., G. Mayer, S. K. Park, and T. W. Meyer. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90: 766-771, 1992.
39. Lee, M., M. Böhm, S. Kim, S. Bachmann, J. Bachmann, M. Bader, and D. Ganten. Differential gene expression of renin and angiotensinogen in the TGR(mREN2)27 transgenic rat. Hypertension Dallas 25: 570-580, 1995.
40. Lee, M., Y. Zhao, J. Peters, D. Ganten, F. Zimmennann, U. Ganten, S. Bachmann, M. Bader, and J. J. Mullins. Preparation and analysis of transgenic rats expressing the mouse Ren-2 gene. J. Vasc. Med. Biol. 3: 50-54, 1991.
41. Lemmer, B., A. Mattes, M. Böhm, and D. Ganten. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension Dallas 22: 97-101, 1993.
42. Levens, N. R., M. J. Peach, and R. M. Carey. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ. Res. 48: 157-167, 1981.
43. Lifton, R. P., R. G. Dluhy, M. Powers, G. M. Rich, S. Cook, S. Ulick, and J.-M. Lalouel. A chimaeric 11β-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature Lond. 355: 262-265, 1992.
44. Lindpaintner, K. Genetic linkage analysis in hypertension: principles and practice. J. Hypertens. 10: 121-124, 1992.
45. Lindpaintner, K., and D. Ganten. The cardiac renin-angiotensin system - an appraisal of present experimental and clinical evidence. Circ. Res. 68: 905-921, 1991.
46. Mitchell, K. D., and J. J. Mullins. ANG II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F821-F828, 1995.
47. Moriguchi, A., K. B. Brosnihan, H. Kumagai, D. Ganten, and C. M. Ferrario. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1273-R1279, 1994.
48. Moriguchi, A., C. M. Ferrario, K. B. Brosnihan, D. Ganten, and M. Morris. Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R786-R791, 1994.
49. Moriguchi, A., E. A. Tallant, K. Matsumura, T. M. Reilly, H. Walton, D. Ganten, and C. M. Ferrario. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension Dallas 25: 1260-1265, 1995.
50. Müller, J. Monographs on Endocrinology, Regulation of Aldosterone Biosynthesis: Physiological and Clinical Aspects. Berlin: Springer Verlag, vol. 29, 1988.
51. Mullins, J. J., J. Peters, and D. Ganten. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature Lond. 344: 541-544, 1990.
52. Mullins, J. J., C. D. Sigmund, C. Kane-Haas, R. A. McGowan, and K. W. Gross. Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice. EMBO J. 8: 4065-4072, 1989.
53. Naftilan, A. J., R. E. Pratt, C. S. Eldridge, H. L. Lin, and V. J. Dzau. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension Dallas 13: 706-711, 1989.
54. Nielsen, A. H., and K. Poulsen. Is prorenin of physiological and clinical significance? J. Hypertens. 6: 949-958, 1988.
55. Oliver, W. J., and F. Gross. Unique specificity of mouse angiotensinogen to homologous renin. Proc. Soc. Exp. Biol. Med. 122: 923-926, 1966.
56. Onoyama, K., T. Omae, and T. Inagami. Tissue edema and arterial lesions produced by pure submaxillary gland renin of mouse. Jpn. Heart J. 19: 522-530, 1978.
57. Paul, M., Y. M. Pinto, H. Schunkert, D. Ganten, and M. Böhm. Activation of the renin-angiotensin system in heart failure and hypertrophy - studies in human hearts and transgenic rats. Eur. Heart J. 15: 63-67, 1994.
58. Paul, M., J. Wagner, and V. J. Dzau. Gene expression of the components of the renin-angiotensin system in human tissues: quantitative analysis by the polymerase chain reaction. J. Clin. Invest. 91: 2058-2064, 1993.
59. Peters, J., K. Münter, M. Bader, E. Hackenthal, J. J. Mullins, and D. Ganten. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II and calcium. J. Clin. Invest. 91: 742-747, 1993.
60. Phillips, M. I. Functions of angiotensin in the central nervous system. Annu. Rev. Physiol. 49: 413-435, 1987.
61. Rapp, J. P. Genetics of experimental and human hypertension. In: Hypertension, edited by J. Genest, O. Kuchel, P. Hamet, and M. Cantin. New York: McGraw-Hill, 1983, p. 582-598.
62. Rapp, J. P., S. M. Wang, and H. Dene. Mutations in the renin gene of Dahl rats. Hypertension Dallas 12: 339-342, 1988.
63. Rong, P., J. L. Berka, D. J. Kelly, D. Alcorn, and S. L. Skinner. Renin processing and secretion in adrenal and retina of transgenic (mREN2)27 rats. Kidney Int. 46: 1583-1587, 1994.
64. Rubattu, S., I. Enea, D. Ganten, D. Salvatore, G. Condorelli, G. Condorelli, R. Russo, M. Romano, B. Gigante, B. Trimarco, and M. Volpe. Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR (mREN2)27. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E515-E520, 1994.
65. Sadoshima, J., Y. Xu, H. S. Slayter, and S. Izumo. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993.
66. Sander, M., M. Bader, B. Djavidani, C. Maser-Gluth, P. Vecsei, J. Mullins, D. Ganten, and J. Peters. The role of the adrenal gland in the hypertensive transgenic rats TGR(m-REN2)27. Endocrinology 131: 807-814, 1992.
67. Sander, M., D. Ganten, and S. H. Mellon. Role of adrenal renin in the regulation of adrenal steroidogenesis by corticotropin. Proc. Natl. Acad. Sci. USA 91: 148-152, 1994.
68. Schunkert, H., L. Jahn, S. Izumo, C. S. Apstein, and B. H. Lorell. Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proc. Natl. Acad. Sci. USA 88: 11480-11484, 1991.
69. Senanayake, P., A. Moriguchi, H. Kumagai, D. Ganten, C. M. Ferrario, and K, B. Brosnihan. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 15: 919-926, 1994.
70. Shimkets, R. A., D. G. Warnock, C. M. Bositis, C. Nelson-Williams, J. H. Hansson, M. Schambelan, J. R. Gill, S. Ulick, R. V. Milora, J. W. Findling, C. M. Canessa, B. C. Rossier, and R. P. Lifton. Liddles syndrome: heritable human hypertension caused by mutations in the β-subunit of the epithelial sodium channel. Cell 79: 407-414, 1994.
71. Sigmund, C. D., and K. W. Gross. Structure, expression, and regulation of the murine renin genes. Hypertension Dallas 18: 446-457, 1991.
72. Sigmund, C. D., C. A. Jones, J. R. Fabian, J. J. Mullins, and K. W. Gross. Tissue and cell specific expression of a renin promoter-T-antigen-reporter gene construct in transgenic mice. Biochem. Biophys. Res. Commun. 170: 344-350, 1990.
73. Skinner, S. L., R. L. Thatcher, J. A. Whitworth, and J. D. Horowitz. Extraction of plasma prorenin by human heart. Lancet 1: 995-997, 1986.
74. Smithies, O., and M. Nobuyo. Gene targeting approaches to complex genetic diseases: arteriosclerosis and essential hypertension. Proc. Natl. Acad. Sci. USA 92: 5266-5272, 1995.
75. Springate, J. E., L. G. Feld, and D. Ganten. Renal function in hypertensive rats transgenic for mouse renin gene. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F731-F737, 1994.
76. Susuki, J., H. Matsubara, M. Urakami, and M. Inada. Rat angiotensin II (type-1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ. Res. 73: 439-447, 1993.
77. Tang, S. S., and V. J. Dzau. Partial purification of a prorenin activating enzyme in the aortic wall. Clin. Exp. Hypertens. A 10: 1251-1257, 1988.
78. TawÆk-Schlieper, H., M. Moll, B. Schmid, R. H. Schwinger, M. Paul, D. Ganten, and M. Bøhm. Alterations of cardiac α-and β-adrenoreceptors and inotropic responsiveness in hypertensive transgenic rats harboring the mouse renin gene (TGR(m-REN2)27). Clin. Exp. Hypertens. 17: 631-648, 1995.
79. Thybo, N. K., N. Korsgaard, and M. J. Mulvany. Morphology and function of mesenteric resistance arteries in transgenic rats with low-renin hypertension. J. Hypertens. 10: 1191-1196, 1992.
80. Tokita, Y., R. Franco-Saenz, P. J. Mulrow, and D. Ganten. Effects of nephrectomy and adrenalectomy on the renin-aagiotensin system of transgenic rats TGR(mRen2)27. Endocrinology 134: 253-257, 1994.
81. Tokita, Y., R. Franco-Saenz, E. M. Reimann, and P. J. Mulrow. Hypertension in the transgenic rat TGR(mRen2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension Dallas 23: 422-427, 1994.
82. Tronik, D., and F. Rougeon. Thyroxine and testosterone transcriptionally regulate renin gene expression in the submaxillary gland of normal and transgenic mice carrying extra copies of the Ren-2 gene. FEBS Lett. 234: 336-340, 1988.
83. Tschudi, M. R., G. Noll, U. Arnet, D. Novosel, D. Ganten, and T. F. Luscher. Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats. Circulation 89: 2780-2786, 1994.
84. Unger, T., B. Schull, D. Hubner, T. Yukimura, R. E. Lang, W. Rascher, and D. Ganten. Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captopril. Eur. J. Pharmacol. 72: 255-259, 1981.
85. Volpe, M., S. Rubattu, B. Gigante, D. Ganten, A. Porcellini, R. Russo, M. Romano, I. Enea, M. Lee, and B. Trimarco. Regulation of aldosterone biosynthesis by adrenal renin is mediated through AT1 receptors in renin transgenic rats. Circ. Res. 77: 73-79, 1995.
86. Waeber, B., H. R. Brunner, D. B. Brunner, A. L. Curtet, G. A. Turini, and H. Gavras. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril Hypertension Dallas 2: 236-242, 1980.
87. Wagner, D., R. Metzger, M. Paul, G. Ludwig, F. Suzuki, S. Takahashi, K. Murakami, and D. Ganten. Androgen dependence and tissue specificity of renin messenger RNA expression in mice. J. Hypertens. 8: 45-52, 1990.
88. Whitworth, C. E., S. Fleming, A. D. Cumming, J. J. Morton, N. J. T. Burns, B. C. Williams, and J. J. Mullins. Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats. Kidney Int. 46: 1528-1532, 1994.
89. Wu, J. N., and K. H. Berecek. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension Dallas 22: 139-146, 1993.
90. Yamaguchi, T., Z. Naito, G. D. Stoner, R. Franco-Saenz, and P. J. Mulrow. Role of the adrenal renin-angiotensin system, on adrenocorticotropic hormone- and potassium-stimulated aldosterone production by rat adrenal glomerulosa cells in monolayer culture Hypertension Dallas 16: 635-641, 1990.
91. Yamaguchi, T., Y. Tokita, R. Franco-Saenz, P. J. Mulrow, J. Peters, and D. Ganten. Zonal distribution and regulation of adrenal renin in a transgenic model of hypertension in the rat. Endocrinology 131: 1955-1962, 1992.
92. d renin gene in transgenic hypertensive rats, TGR(mREN2)27. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E699-E707, 1993.